Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000007

CFO AND TREASURER sold 10,000 shares at an average $558.40 ($5,583,999)

  • CFO AND TREASURER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

14 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-06 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $135.42 $1,354,200 28,876 D
2026-04-06 Sale : show line 2 in the form 10b5-1 −120 $552.78 $66,334 28,756 D
2026-04-06 Sale : show line 3 in the form 10b5-1 −437 $553.97 $242,084 28,319 D
2026-04-06 Sale : show line 4 in the form 10b5-1 −1,158 $555.21 $642,937 27,161 D
2026-04-06 Sale : show line 5 in the form 10b5-1 −1,205 $556.06 $670,052 25,956 D
2026-04-06 Sale : show line 6 in the form 10b5-1 −1,840 $557.19 $1,025,229 24,116 D
2026-04-06 Sale : show line 7 in the form 10b5-1 −1,679 $558.31 $937,409 22,437 D
2026-04-06 Sale : show line 8 in the form 10b5-1 −860 $559.47 $481,142 21,577 D
Open-market sales · 10,000 sh · avg $558.40 · $5,583,999

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-06 Exercise or conversion : show line 15 in the form 10b5-1 Stock Option −10,000 112,500 D
Loading xslF345X06/primarydocument.xml…